Business Standard

Monday, December 23, 2024 | 03:30 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

A booster with the current version of the vaccine increased antibodies 25-fold, providing a similar level as observed after two doses

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant
Premium

Naomi Kresge | Bloomberg
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine neutralizes the omicron variant, results that will accelerate booster shot drives around the world. 

A booster with the current version of the vaccine increased antibodies 25-fold, providing a similar level as observed after two doses against the original virus and other variants, the companies said Wednesday.

Blood plasma from people immunized with two doses of the vaccine has neutralizing antibody levels more than 25-fold less versus omicron than against the original strain of the virus, the companies said.

“It’s clear from these preliminary data that protection

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in